Evaluating CD38 as a therapeutic target in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kinder, Michelle [1 ]
Mendonca, Mark [1 ]
Syed, Khaja [1 ]
Parker, Melissa [1 ]
Wilkinson, Patrick [1 ]
Thompson, Edward [1 ]
Chu, Gerald [1 ]
Chiu, Christopher [1 ]
Hutnick, Natalie [1 ]
机构：
[1] Janssen Res & Dev LLC, Spring House, PA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P376
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PET imaging of CD38 expression in non-small cell lung cancer xenografts
    Ehlerding, Emily
    England, Christopher
    Jiangi, Dawei
    Graves, Stephen
    Barnhart, Todd
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [2] CD47 is a promising therapeutic target in non-small cell lung cancer
    Lau, Asa P.
    Kubli, Shawn P.
    Wakeham, Andrew
    Mak, Tak W.
    Thu, Kelsie L.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Prognostic and therapeutic aspects of non-small cell lung cancer (NSCLC)
    Biasco, G
    Tamberi, S
    2ND INTERNATIONAL CONGRESS OF THORAX SURGERY, 1998, : 7 - 8
  • [4] CD38 as a Therapeutic Target
    George T Stevenson
    Molecular Medicine, 2006, 12 : 345 - 346
  • [5] CD38 as a therapeutic target
    Stevenson, George T.
    MOLECULAR MEDICINE, 2006, 12 (11-12) : 345 - 346
  • [6] Unlocking the potential of CD70 as a therapeutic target in non-small cell lung cancer
    Jacobs, Julie
    Pauwels, Patrick
    Rolfo, Christian
    Lardon, Filip
    Deschoolmeester, Vanessa
    Deben, Christophe
    Van den Bossche, Jolien
    Zwaenepoel, Karen
    Hermans, Christophe
    Silence, Karen
    Thibault, Alain
    CANCER RESEARCH, 2015, 75
  • [7] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Shoji, Tetsuaki
    Kikuchi, Eiki
    Kikuchi, Junko
    Takashima, Yuta
    Furuta, Megumi
    Takahashi, Hirofumi
    Tsuji, Kosuke
    Maeda, Makie
    Kinoshita, Ichiro
    Dosaka-Akita, Hirotoshi
    Sakakibara-Konishi, Jun
    Konno, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 843 - 853
  • [8] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Tetsuaki Shoji
    Eiki Kikuchi
    Junko Kikuchi
    Yuta Takashima
    Megumi Furuta
    Hirofumi Takahashi
    Kosuke Tsuji
    Makie Maeda
    Ichiro Kinoshita
    Hirotoshi Dosaka-Akita
    Jun Sakakibara-Konishi
    Satoshi Konno
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 843 - 853
  • [9] Multi-target inhibitors in non-small cell lung cancer (NSCLC)
    Tiseo, M
    Franciosi, V
    Ardizzoni, A
    ANNALS OF ONCOLOGY, 2006, 17 : 55 - 57
  • [10] Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
    Hall, Richard D.
    Le, Tri M.
    Haggstrom, Daniel E.
    Gentzler, Ryan D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 515 - 523
12345